Search results
Results From The WOW.Com Content Network
t. e. Orlistat (Xenical), the most commonly used medication to treat obesity and sibutramine (Meridia), a medication that was withdrawn due to cardiovascular side effects. Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control excess body fat. These medications alter one of the fundamental processes ...
If less than 3% weight loss is seen after 3 months it is recommended the medication be stopped. The weight loss is modest. Effects on heart related health problems or death is unclear. Common side effects include tingling, dizziness, trouble sleeping, and constipation. Serious side effects may include suicide, abuse.
Here are the key facts: Topiramate could help you lose weight. Research shows it can promote weight loss, reduce BMI and improve blood sugar control. It can act as an appetite suppressant and help ...
Pfizer announced on Dec. 1 that it was discontinuing phase 3 clinical trials of the twice-daily version due to high rates of adverse side effects. While these were mostly mild, a large percentage ...
Dexatrim. Dexatrim is an over-the-counter (OTC) dietary supplement meant to assist with weight loss. Dexatrim claims it "gives you the power to lose weight, curb binges, and keep you in control of your diet." [1] Current Dexatrim products available are in capsule form and include Dexatrim Max Complex 7, Dexatrim Max Daytime Appetite Control ...
Naltrexone/bupropion, sold under the brand name Contrave among others, is a fixed-dose combination medication for the management of chronic obesity in adults in combination with a reduced-calorie diet and increased physical activity. [4] [6] It contains naltrexone, an opioid antagonist, and bupropion, an aminoketone atypical antidepressant. [4]
Lilly's mid-stage trial showed its experimental pill led to 14.7% weight loss after 36 weeks for people who were obese or overweight.
May 8, 2024 at 9:12 AM. (Reuters) - Health and wellness products retailer Vitamin Shoppe said on Wednesday that subscribers to its telehealth service would have access to weight-loss medications ...